By proceeding, you agree to our Terms of Use and Privacy Policy.
Daniel Lagassé conducts research and CMC review as a Biologist in the Division of Plasma Protein Therapeutics within the Center of Biologics Evaluation and Research at the U.S. Food and Drug Administration. Dr.
Talks About #Microbiology #Immunology
Preferred Locations #NorthAmerica
CHI is excited to host its 14th Annual Immunogenicity & Bioassay Summit – a “Live” In-Person & Virtual event. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches.
